←Back to Expert Scholars
Translational Medicine / 转化医学CAR-T Manufacturing, BCMA and CD19
James Kochenderfer
MD
🏢National Cancer Institute🌐USA
Senior Investigator
80
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
James Kochenderfer developed the first BCMA CAR-T used clinically for multiple myeloma and early CD19 CAR-T constructs at the NCI. His laboratory engineers and manufactures CAR-T products for first-in-human trials. He has shaped CAR-T target discovery.
Share:
🧪Research Fields 研究领域
BCMA CAR-T
CD19 CAR-T
myeloma
CAR-T manufacturing
adoptive cell therapy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 James Kochenderfer 的研究动态
Follow James Kochenderfer's research updates
留下邮箱，当我们发布与 James Kochenderfer（National Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment